Skip to main content
. Author manuscript; available in PMC: 2013 Nov 18.
Published in final edited form as: JAMA. 2011 Sep 21;306(11):10.1001/jama.2011.1333. doi: 10.1001/jama.2011.1333

Table 6.

Use and Reported Effectiveness of Medications and Devices for Erectile Dysfunction 2 Years After Primary Prostate Cancer Treatment Among 694 Men Who Had Reported Functional Erections Suitable for Intercourse Pretreatment in the PROSTQA Cohorta

Medication or Device Patient-Reported Effectiveness, No. (%)b

Have Not
Tried It
Ineffective
(Tried It
But It
Was Not
Helpful)
Effective

I Use It
Always
I Use It
Sometimes
It Helped,
But I Am Not
Using It Now
PDE-5 inhibitors
Prostatectomy (n = 412) 131 (32) 111 (27) 51 (12) 86 (21) 33 (8)

External radiotherapy (n = 120) 72 (60) 10 (8) 11 (9) 22 (18) 5 (4)

Brachytherapy (n = 162) 75 (46) 13 (8) 29 (18) 34 (21) 11 (7)

Overall (of 416 trying) 134 (32) 91 (22) 142 (34) 49 (12)

Intraurethral alprostadil
Prostatectomy (n = 412) 351 (85) 31 (8) 5 (1) 13 (3) 12 (3)

External radiotherapy (n = 120) 115 (96) 1 (1) 1 (1) 2 (2) 0

Brachytherapy (n = 162) 159 (98) 1 (1) 0 0 1 (1)

Overall (of 67 trying) 33 (49) 6 (0) 15 (22) 13 (19)

Penile injections
Prostatectomy (n = 412) 352 (86) 16 (4) 12 (3) 10 (2) 21 (5)

External radiotherapy (n = 120) 116 (97) 1 (1) 0 2 (2) 1 (1)

Brachytherapy (n = 162) 159 (98) 0 0 0 3 (2)

Overall (of 66 trying) 17 (26) 12 (18) 12 (18) 25 (38)

Vacuum erection device
Prostatectomy (n = 412) 332 (81) 27 (7) 12 (3) 21 (5) 20 (5)

External radiotherapy (n = 120) 115 (97) 0 1 (1) 1 (1) 1 (1)

Brachytherapy (n = 162) 161 (99) 0 0 0 1 (1)

Overall (of 84 trying) 27 (32) 13 (15) 22 (26) 22 (26)

Abbreviations: PDE-5, phosphodiesterase 5; PROSTQA, Prostate Cancer Outcomes and Satisfaction With Treatment Quality Assessment.

a

Use of medications or devices was measured by a previously described standard question set for use with the Expanded Prostate Cancer Index Composite.18 From among 694 men across all 3 treatment groups who reported erections suitable for intercourse at baseline, 328 reported erections suitable for intercourse at 2 years after treatment; 199 (61% [95% CI, 55%–66%]) of these 328 reported use of aids or medications for erectile dysfunction. Of the remaining 352 who reported erections not suitable for intercourse at 2 years, 218 (62% [95% CI, 57%–67%]) reported use of aids or medications for erectile dysfunction.

b

Values may not sum to total number of patients because of occasional missing values. Medications and devices considered effective if response was “I use it always,” “I use it sometimes,” or “It helped, but I am not using it now”; denominator for response rates is limited to patients reporting having tried the medication/device.